BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30178275)

  • 1. Induction of HRR genes and inhibition of DNMT1 is associated with anthracycline anti-tumor antibiotic-tolerant breast carcinoma cells.
    Dasgupta H; Islam MS; Alam N; Roy A; Roychoudhury S; Panda CK
    Mol Cell Biochem; 2019 Mar; 453(1-2):163-178. PubMed ID: 30178275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomethylation of mismatch repair genes MLH1 and MSH2 is associated with chemotolerance of breast carcinoma: Clinical significance.
    Dasgupta H; Islam S; Alam N; Roy A; Roychoudhury S; Panda CK
    J Surg Oncol; 2019 Jan; 119(1):88-100. PubMed ID: 30481381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent alterations of homologous recombination repair pathway in primary and chemotolerant breast carcinomas: clinical importance.
    Dasgupta H; Mukherjee N; Islam S; Bhattacharya R; Alam N; Roy A; Roychoudhury S; Biswas J; Panda CK
    Future Oncol; 2017 Jan; 13(2):159-174. PubMed ID: 27646721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of nuclear Y654-p-β-catenin expression through SH3GL2-meditated downregulation of EGFR in chemotolerance TNBC: Clinical and prognostic importance.
    Islam MS; Dasgupta H; Basu M; Roy A; Alam N; Roychoudhury S; Kumar Panda C
    J Cell Physiol; 2020 Nov; 235(11):8114-8128. PubMed ID: 31960967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Int J Oncol; 2010 May; 36(5):1235-41. PubMed ID: 20372798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
    Buocikova V; Longhin EM; Pilalis E; Mastrokalou C; Miklikova S; Cihova M; Poturnayova A; Mackova K; Babelova A; Trnkova L; El Yamani N; Zheng C; Rios-Mondragon I; Labudova M; Csaderova L; Kuracinova KM; Makovicky P; Kucerova L; Matuskova M; Cimpan MR; Dusinska M; Babal P; Chatziioannou A; Gabelova A; Rundén-Pran E; Smolkova B
    Biomed Pharmacother; 2022 Mar; 147():112662. PubMed ID: 35091237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells.
    Chewchuk S; Guo B; Parissenti AM
    PLoS One; 2017; 12(2):e0172244. PubMed ID: 28196134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152.
    Li Z; Li Y; Li Y; Ren K; Li X; Han X; Wang J
    J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28544374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.
    Motawi TK; El-Maraghy SA; Sabry D; Nady OM; Senousy MA
    Chem Biol Interact; 2022 Sep; 365():110094. PubMed ID: 35961540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin-paclitaxel sequential treatment: insights of DNA methylation and gene expression changes of luminal A and triple negative breast cancer cell lines.
    Hamadneh L; Abu-Irmaileh B; Al-Majawleh M; Bustanji Y; Jarrar Y; Al-Qirim T
    Mol Cell Biochem; 2021 Oct; 476(10):3647-3654. PubMed ID: 34050450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kindlin-2 interacts with and stabilizes DNMT1 to promote breast cancer development.
    Wang P; Chu W; Zhang X; Li B; Wu J; Qi L; Yu Y; Zhang H
    Int J Biochem Cell Biol; 2018 Dec; 105():41-51. PubMed ID: 30287284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1.
    Qin T; Huang G; Chi L; Sui S; Song C; Li N; Sun S; Li N; Zhang M; Zhao Z; Li L; Li M
    Biomed Pharmacother; 2017 Nov; 95():649-655. PubMed ID: 28881292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH; Li G; Yu J; Xu MS; Liu ZX
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer.
    Gu X; Xue JQ; Han SJ; Qian SY; Zhang WH
    Cancer Biomark; 2016; 16(3):395-403. PubMed ID: 27062696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
    Chen F; Luo N; Hu Y; Li X; Zhang K
    Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
    Tsou SH; Chen TM; Hsiao HT; Chen YH
    PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells.
    Lu Y; Wang L; Li H; Li Y; Ruan Y; Lin D; Yang M; Jin X; Guo Y; Zhang X; Quan C
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications.
    Islam S; Dasgupta H; Basu M; Roy A; Alam N; Roychoudhury S; Panda CK
    Cell Oncol (Dordr); 2020 Aug; 43(4):725-741. PubMed ID: 32430683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.
    Dong T; Zhang M; Dong Y; Herman JG; van Engeland M; Zhong G; Guo M
    Discov Med; 2015 Nov; 20(111):261-71. PubMed ID: 26645898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine.
    Ari F; Napieralski R; Ulukaya E; Dere E; Colling C; Honert K; Krüger A; Kiechle M; Schmitt M
    Cell Biochem Funct; 2011 Dec; 29(8):651-9. PubMed ID: 21887697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.